US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Celularity Inc.

3.06

-0.1700-5.26%

Post-market: 3.01-0.0482-1.58%19:57 EDT

Volume:47.79K

Turnover:148.13K

Market Cap:75.55M

PE:-1.16

High:3.22

Open:3.20

Low:3.03

Close:3.23

52wk High:5.22

52wk Low:1.00

Shares:24.69M

Float Shares:12.93M

Volume Ratio:1.04

T/O Rate:0.37%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.6446

EPS(LYR):-2.6446

ROE:-232.51%

ROA:-17.42%

PB:8.55

PE(LYR):-1.16

Loading ...

Overview Company News Filings

Celularity Inc. Faces Nasdaq Delisting Risk Over Delayed Financial Reports

Celularity Inc. Announces $2 Million Private Placement with Institutional Investor for Working Capital and Corporate Purposes

Celularity Inc. Announces $1.035 Million Private Placement of Common Stock with Warrant Adjustments

Celularity Inc. Files Initial Beneficial Ownership Statement for Interim CFO Joseph DosSantos

Celularity Inc. Files Initial Statement of Beneficial Ownership for Director Vincent LeVien

BRIEF-Celularity Announces Chief Financial Officer Transition

Celularity Inc. Appoints Interim CFO Joseph DosSantos Following David Beers' Departure

Press Release: Celularity Announces Chief Financial Officer Transition

Celularity Inc. Appoints Vincent LeVien as New Class II Director and Committee Member

Celularity Inc. Files Amendment to 10-K Annual Report

Celularity Inc. Extends Promissory Note Maturity, Issues 100,000 Shares with Piggyback Registration Rights

Celularity Inc. Announces Resignation of Board Director Dean Kehler, Citing No Disagreements

Celularity Inc. Advances Placental-Derived Therapies

Press Release: Celularity Announces Full Year 2024 Operating and Financial Results

Celularity Inc. Reports Significant Variation in Net Revenues and Maintains Investment Focus Despite Short-Term Profitability Challenges

Celularity receives notice regarding non-payment of Nasdaq fees

Celularity welcomes CMS action on Medicare LCD for skin substitutes products

Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products

Celularity Announces Publication of “Senescence, NK cells, and cancer: navigating the crossroads of aging and disease” in the April 4, 2025, Issue of Frontiers in Immunology

BRIEF-Celularity Files For Non-Timley 10-K - SEC Filing

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CELU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CELU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CELU\",,,,,undefined,":{"symbol":"CELU","market":"US","secType":"STK","nameCN":"Celularity Inc.","latestPrice":3.06,"timestamp":1755028800000,"preClose":3.23,"halted":0,"volume":47785,"hourTrading":{"tag":"盘后","latestPrice":3.0118,"preClose":3.06,"latestTime":"19:57 EDT","volume":262,"amount":791.4268,"timestamp":1755043033428},"delay":0,"floatShares":12928916,"shares":24688515,"eps":-2.644615,"marketStatus":"Closed","change":-0.17,"latestTime":"08-12 16:00:00 EDT","open":3.2,"high":3.215,"low":3.03,"amount":148134.0877555,"amplitude":0.057276,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.644615,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1755072000000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":3.23,"postHourTrading":{"tag":"盘后","latestPrice":3.0118,"preClose":3.06,"latestTime":"19:57 EDT","volume":262,"amount":791.4268,"timestamp":1755043033428},"volumeRatio":1.042371,"impliedVol":1.3885,"impliedVolPercentile":0.656},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CELU\",,,,,undefined,":{"symbol":"CELU","floatShares":12928916,"roa":"-17.42%","roe":"-232.51%","lyrEps":-2.644615,"volumeRatio":1.042371,"shares":24688515,"dividePrice":0,"high":3.215,"amplitude":0.057276,"preClose":3.23,"low":3.03,"week52Low":1.0007,"pbRate":"8.55","psRate":"1.39","week52High":5.22,"institutionHeld":0,"latestPrice":3.06,"eps":-2.644615,"divideRate":0,"volume":47785,"delay":0,"ttmEps":-2.644615,"open":3.2,"prevYearClose":2.08,"prevWeekClose":3.24,"prevMonthClose":3.28,"prevQuarterClose":1.96,"fiveDayClose":3.29,"twentyDayClose":2.48,"sixtyDayClose":1.99},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CELU\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-09","symbol":"CELU","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746763200000,"reportTimeType":"pre","actualEps":-0.59},{"market":"US","date":"2024-12-06","symbol":"CELU","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1733461200000,"reportTimeType":"pre","actualEps":-0.73},{"date":"2024-10-16","symbol":"CELU","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1729108800000,"name":null,"time":"Post Market","dateTimestamp":1729051200000,"actualEps":null},{"date":"2024-07-30","symbol":"CELU","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722369600000,"name":null,"time":"Post Market","dateTimestamp":1722312000000,"actualEps":null},{"market":"US","date":"2024-02-29","symbol":"CELU","defaultRemindTime":1709217000000,"type":"split","dateTimestamp":1709182800000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CELU\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CELU\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CELU\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CELU","date":"2025-08-11","current":-1.381724,"percent":0.409045,"low":-21.627108,"twenty":-6.791544,"median":-0.870814,"eighty":-0.314714,"high":15.000765,"avg":-2.114106,"sd":6.597202,"marketCap":79990788},"quantilePoints":[{"date":"2021-07-16","current":-4.813189,"twenty":-4.813189,"median":-4.813189,"eighty":-4.813189,"marketCap":1249369134},{"date":"2021-07-23","current":-4.600843,"twenty":-5.211929,"median":-4.707016,"eighty":-4.482872,"marketCap":1194249907},{"date":"2021-07-30","current":-4.152555,"twenty":-4.813189,"median":-4.478153,"eighty":-4.152555,"marketCap":1077887096},{"date":"2021-08-06","current":-3.633486,"twenty":-4.600843,"median":-4.225697,"eighty":-4.032226,"marketCap":943151209},{"date":"2021-08-13","current":-3.067228,"twenty":-4.482872,"median":-4.152555,"eighty":-3.633486,"marketCap":796166605},{"date":"2021-08-20","current":-3.932725,"twenty":-4.478153,"median":-4.152555,"eighty":-3.765613,"marketCap":741047378},{"date":"2021-08-27","current":-5.297804,"twenty":-4.600843,"median":-4.171431,"eighty":-3.77505,"marketCap":998270435},{"date":"2021-09-03","current":-5.655324,"twenty":-5.211929,"median":-4.301621,"eighty":-3.932725,"marketCap":1065638379},{"date":"2021-09-10","current":-4.335748,"twenty":-5.093418,"median":-4.351999,"eighty":-3.934937,"marketCap":816989423},{"date":"2021-09-17","current":-4.056232,"twenty":-4.863309,"median":-4.312995,"eighty":-3.985281,"marketCap":764319940},{"date":"2021-09-24","current":-5.050789,"twenty":-5.053389,"median":-4.324371,"eighty":-3.997729,"marketCap":951725310},{"date":"2021-10-01","current":-4.667267,"twenty":-4.873979,"median":-4.387751,"eighty":-4.025327,"marketCap":879457880},{"date":"2021-10-08","current":-4.647766,"twenty":-4.819376,"median":-4.423503,"eighty":-4.051431,"marketCap":875783265},{"date":"2021-10-15","current":-4.673768,"twenty":-4.813906,"median":-4.465756,"eighty":-4.061433,"marketCap":880682752},{"date":"2021-10-22","current":-4.478757,"twenty":-4.813906,"median":-4.478455,"eighty":-4.083534,"marketCap":843936601},{"date":"2021-10-29","current":-4.387751,"twenty":-4.774456,"median":-4.465756,"eighty":-4.090716,"marketCap":826788397},{"date":"2021-11-05","current":-4.738772,"twenty":-4.743972,"median":-4.478455,"eighty":-4.10483,"marketCap":892931469},{"date":"2021-11-12","current":-9.524237,"twenty":-4.743972,"median":-4.478757,"eighty":-4.143691,"marketCap":877829843},{"date":"2021-11-19","current":-9.350094,"twenty":-4.833677,"median":-4.54376,"eighty":-4.152555,"marketCap":861779508},{"date":"2021-11-26","current":-9.041997,"twenty":-5.097592,"median":-4.576263,"eighty":-4.153265,"marketCap":833382762},{"date":"2021-12-03","current":-8.131099,"twenty":-5.379708,"median":-4.600843,"eighty":-4.164354,"marketCap":749427165},{"date":"2021-12-10","current":-7.568486,"twenty":-5.686538,"median":-4.618514,"eighty":-4.172516,"marketCap":697572238},{"date":"2021-12-17","current":-6.242327,"twenty":-6.65491,"median":-4.647766,"eighty":-4.237273,"marketCap":575342766},{"date":"2021-12-23","current":-6.295909,"twenty":-6.579894,"median":-4.660767,"eighty":-4.284076,"marketCap":580281331},{"date":"2021-12-31","current":-6.858522,"twenty":-6.711171,"median":-4.670517,"eighty":-4.295446,"marketCap":632136258},{"date":"2022-01-07","current":-6.161953,"twenty":-6.751358,"median":-4.686769,"eighty":-4.305847,"marketCap":567934919},{"date":"2022-01-14","current":-5.545758,"twenty":-6.711171,"median":-4.703019,"eighty":-4.311046,"marketCap":511141427},{"date":"2022-01-21","current":-5.786878,"twenty":-6.692417,"median":-4.729021,"eighty":-4.317546,"marketCap":533364968},{"date":"2022-01-28","current":-5.706505,"twenty":-6.612044,"median":-4.764773,"eighty":-4.342248,"marketCap":525957121},{"date":"2022-02-04","current":-5.96102,"twenty":-6.577215,"median":-4.823277,"eighty":-4.37215,"marketCap":549415302},{"date":"2022-02-11","current":-7.367553,"twenty":-6.612044,"median":-5.050789,"eighty":-4.387751,"marketCap":679052621},{"date":"2022-02-18","current":-8.666921,"twenty":-6.788865,"median":-5.126,"eighty":-4.387751,"marketCap":798812811},{"date":"2022-02-25","current":-9.283117,"twenty":-6.992478,"median":-5.198004,"eighty":-4.387751,"marketCap":855606303},{"date":"2022-03-04","current":-10.311401,"twenty":-7.340762,"median":-5.297804,"eighty":-4.394252,"marketCap":950381218},{"date":"2022-03-11","current":-13.352894,"twenty":-7.689046,"median":-5.388808,"eighty":-4.394252,"marketCap":1230709491},{"date":"2022-03-18","current":-10.385584,"twenty":-8.265055,"median":-5.545758,"eighty":-4.413753,"marketCap":957218493},{"date":"2022-03-25","current":-10.9197,"twenty":-8.653526,"median":-5.604581,"eighty":-4.433254,"marketCap":1006446872},{"date":"2022-04-01","current":-12.215169,"twenty":-8.747295,"median":-5.706505,"eighty":-4.452755,"marketCap":1222958270},{"date":"2022-04-08","current":-12.916716,"twenty":-9.12237,"median":-5.813669,"eighty":-4.465756,"marketCap":1293195739},{"date":"2022-04-14","current":-14.196007,"twenty":-9.339378,"median":-5.90074,"eighty":-4.465756,"marketCap":1421275828},{"date":"2022-04-22","current":-16.396938,"twenty":-9.623364,"median":-6.001207,"eighty":-4.475674,"marketCap":1641628669},{"date":"2022-04-29","current":-16.080834,"twenty":-10.326238,"median":-6.048091,"eighty":-4.478636,"marketCap":1609980899},{"date":"2022-05-06","current":-16.782393,"twenty":-10.584394,"median":-6.135162,"eighty":-4.478757,"marketCap":1680219587},{"date":"2022-05-13","current":-10.096948,"twenty":-10.584394,"median":-6.188745,"eighty":-4.478757,"marketCap":1010886210},{"date":"2022-05-20","current":-12.668524,"twenty":-10.905862,"median":-6.295909,"eighty":-4.482049,"marketCap":1031800612},{"date":"2022-05-27","current":-15.130905,"twenty":-11.27281,"median":-6.309304,"eighty":-4.521182,"marketCap":1232351669},{"date":"2022-06-03","current":-18.94799,"twenty":-11.964813,"median":-6.409771,"eighty":-4.546361,"marketCap":1543237998},{"date":"2022-06-10","current":-8.075619,"twenty":-11.964813,"median":-6.510238,"eighty":-4.560662,"marketCap":657726895},{"date":"2022-06-17","current":-6.817081,"twenty":-11.818849,"median":-6.604007,"eighty":-4.578863,"marketCap":555224003},{"date":"2022-06-24","current":-6.432528,"twenty":-11.701936,"median":-6.557122,"eighty":-4.591863,"marketCap":523903674},{"date":"2022-07-01","current":-6.170333,"twenty":-11.597572,"median":-6.456655,"eighty":-4.597795,"marketCap":502548905},{"date":"2022-07-08","current":-7.533749,"twenty":-11.500977,"median":-6.510238,"eighty":-4.601127,"marketCap":613593705},{"date":"2022-07-15","current":-7.201635,"twenty":-11.441946,"median":-6.598968,"eighty":-4.603564,"marketCap":586544331},{"date":"2022-07-22","current":-6.013015,"twenty":-11.183791,"median":-6.510238,"eighty":-4.612664,"marketCap":489736043},{"date":"2022-07-29","current":-5.261388,"twenty":-11.032458,"median":-6.453331,"eighty":-4.628265,"marketCap":428519038},{"date":"2022-08-05","current":-5.278868,"twenty":-10.943438,"median":-6.416469,"eighty":-4.632165,"marketCap":429942689},{"date":"2022-08-12","current":14.169953,"twenty":-10.916241,"median":-6.316435,"eighty":-4.603564,"marketCap":437242254},{"date":"2022-08-19","current":13.016048,"twenty":-10.873222,"median":-6.295909,"eighty":-4.568462,"marketCap":401636207},{"date":"2022-08-26","current":13.292986,"twenty":-10.738694,"median":-6.27682,"eighty":-4.47958,"marketCap":410181658},{"date":"2022-09-02","current":12.739111,"twenty":-10.655609,"median":-6.215536,"eighty":-4.468235,"marketCap":393090756},{"date":"2022-09-09","current":11.354425,"twenty":-10.608132,"median":-6.170333,"eighty":-4.433254,"marketCap":350363500},{"date":"2022-09-16","current":9.891651,"twenty":-10.578459,"median":-6.14186,"eighty":-4.387751,"marketCap":305226690},{"date":"2022-09-23","current":11.711342,"twenty":-10.533949,"median":-6.117893,"eighty":-4.335748,"marketCap":361376883},{"date":"2022-09-30","current":10.778167,"twenty":-10.519113,"median":-6.074882,"eighty":-4.290246,"marketCap":332581912},{"date":"2022-10-07","current":9.798334,"twenty":-10.385584,"median":-6.027998,"eighty":-4.153738,"marketCap":302347193},{"date":"2022-10-14","current":9.705017,"twenty":-10.311401,"median":-6.001207,"eighty":-4.091211,"marketCap":299467696},{"date":"2022-10-21","current":10.591532,"twenty":-10.296565,"median":-5.96102,"eighty":-4.032226,"marketCap":326822918},{"date":"2022-10-28","current":10.918144,"twenty":-10.281728,"median":-5.84046,"eighty":-3.932725,"marketCap":336901158},{"date":"2022-11-04","current":10.404898,"twenty":-10.096948,"median":-5.733358,"eighty":-3.633486,"marketCap":321063924},{"date":"2022-11-11","current":-20.611751,"twenty":-10.281728,"median":-5.719931,"eighty":-3.067228,"marketCap":294377025},{"date":"2022-11-18","current":-17.768751,"twenty":-10.519113,"median":-5.84046,"eighty":-3.586298,"marketCap":253773297},{"date":"2022-11-25","current":-15.941108,"twenty":-10.620001,"median":-5.943097,"eighty":-3.624048,"marketCap":227670901},{"date":"2022-12-02","current":-17.768751,"twenty":-10.925635,"median":-5.994509,"eighty":-3.633486,"marketCap":253773297},{"date":"2022-12-09","current":-15.738036,"twenty":-11.498988,"median":-6.013015,"eighty":-3.739188,"marketCap":224770635},{"date":"2022-12-16","current":-15.027286,"twenty":-11.95931,"median":-6.066819,"eighty":-3.773163,"marketCap":214619703},{"date":"2022-12-23","current":-11.676608,"twenty":-11.996491,"median":-6.100414,"eighty":-3.90119,"marketCap":166765309},{"date":"2022-12-30","current":-13.098108,"twenty":-12.065084,"median":-6.117893,"eighty":-3.934384,"marketCap":187067173},{"date":"2023-01-06","current":-9.659093,"twenty":-12.026832,"median":-6.148558,"eighty":-3.960386,"marketCap":137951164},{"date":"2023-01-13","current":-10.458179,"twenty":-11.970315,"median":-6.179073,"eighty":-3.997729,"marketCap":149363712},{"date":"2023-01-20","current":-10.762786,"twenty":-11.938982,"median":-6.228931,"eighty":-4.004628,"marketCap":153714111},{"date":"2023-01-27","current":-10.66125,"twenty":-11.859372,"median":-6.295909,"eighty":-4.037027,"marketCap":152263978},{"date":"2023-02-03","current":-9.802258,"twenty":-11.76829,"median":-6.30304,"eighty":-4.057532,"marketCap":139995852},{"date":"2023-02-10","current":-7.414138,"twenty":-11.718422,"median":-6.3227,"eighty":-4.067933,"marketCap":105888721},{"date":"2023-02-17","current":-7.141007,"twenty":-11.676608,"median":-6.424499,"eighty":-4.089229,"marketCap":101987863},{"date":"2023-02-24","current":-6.66582,"twenty":-11.676608,"median":-6.441268,"eighty":-4.091211,"marketCap":95201239},{"date":"2023-03-03","current":-8.122857,"twenty":-11.661527,"median":-6.473917,"eighty":-4.108235,"marketCap":116010650},{"date":"2023-03-10","current":-6.365274,"twenty":-11.50164,"median":-6.482996,"eighty":-4.152555,"marketCap":90908845},{"date":"2023-03-17","current":-6.35458,"twenty":-11.498325,"median":-6.456655,"eighty":-4.152555,"marketCap":90756114},{"date":"2023-03-24","current":-6.343812,"twenty":-11.473536,"median":-6.449138,"eighty":-4.153738,"marketCap":90602316},{"date":"2023-03-31","current":-6.673332,"twenty":-11.473536,"median":-6.450008,"eighty":-4.171431,"marketCap":95308530},{"date":"2023-04-06","current":-7.001776,"twenty":-11.392307,"median":-6.456655,"eighty":-4.172877,"marketCap":99999365},{"date":"2023-04-14","current":7.738659,"twenty":-11.290772,"median":-6.449138,"eighty":-4.143691,"marketCap":109827048},{"date":"2023-04-21","current":8.73053,"twenty":-11.227238,"median":-6.416469,"eighty":-4.061433,"marketCap":123903682},{"date":"2023-04-28","current":7.020007,"twenty":-11.085869,"median":-6.376443,"eighty":-3.985281,"marketCap":99627934},{"date":"2023-05-05","current":6.191951,"twenty":-10.983332,"median":-6.343812,"eighty":-3.739188,"marketCap":87876166},{"date":"2023-05-12","current":6.20303,"twenty":-10.965858,"median":-6.3103,"eighty":-3.05779,"marketCap":88033400},{"date":"2023-05-19","current":7.189064,"twenty":-10.95267,"median":-6.295909,"eighty":5.832497,"marketCap":102027199},{"date":"2023-05-26","current":8.380082,"twenty":-10.925635,"median":-6.27682,"eighty":6.266304,"marketCap":109293026},{"date":"2023-06-02","current":9.607887,"twenty":-10.909322,"median":-6.251201,"eighty":6.523583,"marketCap":125306061},{"date":"2023-06-09","current":9.412712,"twenty":-10.818633,"median":-6.23937,"eighty":6.927911,"marketCap":122760584},{"date":"2023-06-16","current":11.252343,"twenty":-10.762786,"median":-6.179073,"eighty":7.151621,"marketCap":146753058},{"date":"2023-06-23","current":10.353983,"twenty":-10.760271,"median":-6.155255,"eighty":7.333742,"marketCap":135036643},{"date":"2023-06-30","current":7.445732,"twenty":-10.738694,"median":-6.126527,"eighty":7.444497,"marketCap":97107233},{"date":"2023-07-07","current":7.096908,"twenty":-10.667478,"median":-6.109153,"eighty":7.439559,"marketCap":92557870},{"date":"2023-07-14","current":7.073376,"twenty":-10.66125,"median":-6.08158,"eighty":7.387461,"marketCap":92250968},{"date":"2023-07-21","current":7.197956,"twenty":-10.66125,"median":-6.065454,"eighty":7.280023,"marketCap":93875741},{"date":"2023-07-28","current":5.308492,"twenty":-10.66125,"median":-6.018022,"eighty":7.249938,"marketCap":69233359},{"date":"2023-08-04","current":5.548936,"twenty":-10.629379,"median":-6.005057,"eighty":7.247788,"marketCap":72369220},{"date":"2023-08-11","current":4.900811,"twenty":-10.590328,"median":-5.987811,"eighty":7.217889,"marketCap":63916374},{"date":"2023-08-18","current":-0.69471,"twenty":-10.551753,"median":-5.916085,"eighty":7.192621,"marketCap":57475405},{"date":"2023-08-25","current":-0.689863,"twenty":-10.525047,"median":-5.84046,"eighty":7.181941,"marketCap":57074413},{"date":"2023-09-01","current":-0.747794,"twenty":-10.482553,"median":-5.719931,"eighty":7.17304,"marketCap":61867213},{"date":"2023-09-08","current":-0.721252,"twenty":-10.429141,"median":-5.650633,"eighty":7.163655,"marketCap":59671309},{"date":"2023-09-15","current":-0.672553,"twenty":-10.374008,"median":-5.59934,"eighty":7.152324,"marketCap":55642302},{"date":"2023-09-22","current":-0.558306,"twenty":-10.338546,"median":-5.580984,"eighty":7.130552,"marketCap":46190367},{"date":"2023-09-29","current":-0.519994,"twenty":-10.305467,"median":-5.492815,"eighty":7.099399,"marketCap":43020627},{"date":"2023-10-06","current":-0.487451,"twenty":-10.29063,"median":-5.381006,"eighty":7.08962,"marketCap":40328257},{"date":"2023-10-13","current":-0.623161,"twenty":-10.27108,"median":-5.313827,"eighty":7.076564,"marketCap":51556011},{"date":"2023-10-20","current":-0.576078,"twenty":-10.191844,"median":-5.270128,"eighty":7.056765,"marketCap":47660668},{"date":"2023-10-27","current":-0.470833,"twenty":-10.12858,"median":-5.242826,"eighty":7.040154,"marketCap":38953430},{"date":"2023-11-03","current":-0.507761,"twenty":-9.939988,"median":-5.184078,"eighty":7.027957,"marketCap":42008601},{"date":"2023-11-10","current":-0.499914,"twenty":-9.860134,"median":-5.126,"eighty":7.021402,"marketCap":41359377},{"date":"2023-11-17","current":-0.461601,"twenty":-9.811802,"median":-5.06379,"eighty":6.94089,"marketCap":38189638},{"date":"2023-11-24","current":-0.492759,"twenty":-9.797492,"median":-4.911794,"eighty":6.921111,"marketCap":40767438},{"date":"2023-12-01","current":-0.491605,"twenty":-9.713181,"median":-4.839527,"eighty":6.904501,"marketCap":40671964},{"date":"2023-12-08","current":-0.483527,"twenty":-9.650515,"median":-4.813189,"eighty":6.890935,"marketCap":40003645},{"date":"2023-12-15","current":-0.464601,"twenty":-9.639363,"median":-4.735521,"eighty":6.875617,"marketCap":38437870},{"date":"2023-12-22","current":-0.417749,"twenty":-9.633083,"median":-4.70627,"eighty":6.827846,"marketCap":34561622},{"date":"2023-12-29","current":-0.431597,"twenty":-9.628651,"median":-4.696519,"eighty":6.798192,"marketCap":35707311},{"date":"2024-01-05","current":-0.272393,"twenty":-9.620667,"median":-4.686769,"eighty":6.786565,"marketCap":49414318},{"date":"2024-01-12","current":-0.267159,"twenty":-9.585856,"median":-4.670517,"eighty":6.782689,"marketCap":48464788},{"date":"2024-01-19","current":-0.308712,"twenty":-9.54567,"median":-4.660767,"eighty":6.770958,"marketCap":56002894},{"date":"2024-01-26","current":-0.415138,"twenty":-9.487572,"median":-4.647766,"eighty":6.683368,"marketCap":75309371},{"date":"2024-02-02","current":-0.582267,"twenty":-9.438761,"median":-4.618514,"eighty":6.566668,"marketCap":105627885},{"date":"2024-02-09","current":-0.47717,"twenty":-9.379062,"median":-4.600843,"eighty":6.523583,"marketCap":86562496},{"date":"2024-02-16","current":-0.487907,"twenty":-9.342057,"median":-4.576263,"eighty":6.509796,"marketCap":88510152},{"date":"2024-02-23","current":-0.517133,"twenty":-9.315266,"median":-4.54376,"eighty":6.461049,"marketCap":93812105},{"date":"2024-03-01","current":-0.427067,"twenty":-9.283117,"median":-4.478757,"eighty":6.333763,"marketCap":77473433},{"date":"2024-03-08","current":-0.654916,"twenty":-9.271863,"median":-4.478455,"eighty":6.220756,"marketCap":118807025},{"date":"2024-03-15","current":-0.679968,"twenty":-9.222489,"median":-4.465756,"eighty":6.202045,"marketCap":123351556},{"date":"2024-03-22","current":-0.643611,"twenty":-9.163598,"median":-4.423503,"eighty":6.197121,"marketCap":116756134},{"date":"2024-03-28","current":-0.593179,"twenty":-9.143168,"median":-4.394252,"eighty":6.130915,"marketCap":107607333},{"date":"2024-04-05","current":-0.614792,"twenty":-9.106295,"median":-4.387751,"eighty":5.857945,"marketCap":111528248},{"date":"2024-04-12","current":-0.558356,"twenty":-9.04134,"median":-4.351999,"eighty":5.733183,"marketCap":101290303},{"date":"2024-04-19","current":-0.385446,"twenty":-9.025972,"median":-4.309747,"eighty":5.68929,"marketCap":69922983},{"date":"2024-04-26","current":-0.368635,"twenty":-8.945549,"median":-4.285105,"eighty":5.662745,"marketCap":66873383},{"date":"2024-05-03","current":-0.374639,"twenty":-8.811593,"median":-4.171431,"eighty":5.632989,"marketCap":67962526},{"date":"2024-05-10","current":-0.366234,"twenty":-8.747295,"median":-4.152555,"eighty":5.532987,"marketCap":66437726},{"date":"2024-05-17","current":-0.366234,"twenty":-8.73122,"median":-4.091211,"eighty":5.43705,"marketCap":66437726},{"date":"2024-05-24","current":-0.416666,"twenty":-8.666921,"median":-4.059482,"eighty":5.296843,"marketCap":75586527},{"date":"2024-05-31","current":-0.357828,"twenty":-8.666921,"median":-4.014977,"eighty":5.250247,"marketCap":64912925},{"date":"2024-06-07","current":-0.389048,"twenty":-8.666318,"median":-3.93549,"eighty":5.212072,"marketCap":70576469},{"date":"2024-06-14","current":-0.390249,"twenty":-8.656084,"median":-3.77505,"eighty":5.170695,"marketCap":70794298},{"date":"2024-06-21","current":-0.366234,"twenty":-8.637451,"median":-3.633486,"eighty":5.109023,"marketCap":66437726},{"date":"2024-06-28","current":-0.336215,"twenty":-8.626735,"median":-3.633486,"eighty":5.074804,"marketCap":60992010},{"date":"2024-07-05","current":-0.365033,"twenty":-8.583869,"median":-3.067228,"eighty":4.93561,"marketCap":66219897},{"date":"2024-07-12","current":-0.347021,"twenty":-8.538643,"median":-0.830348,"eighty":4.855985,"marketCap":62952468},{"date":"2024-07-15","current":-0.354226,"twenty":-8.530016,"median":-0.830276,"eighty":4.844778,"marketCap":64259439},{"date":"2024-08-02","current":-0.381745,"twenty":-8.529813,"median":-0.799421,"eighty":4.840035,"marketCap":69251534},{"date":"2024-08-09","current":-0.310234,"twenty":-8.50836,"median":-0.747794,"eighty":4.784815,"marketCap":60897380},{"date":"2024-08-16","current":-0.330394,"twenty":-8.425118,"median":-0.736741,"eighty":3.671628,"marketCap":64854611},{"date":"2024-08-23","current":-0.348716,"twenty":-8.403096,"median":-0.732792,"eighty":-0.203622,"marketCap":68451294},{"date":"2024-08-30","current":-0.33465,"twenty":-8.313754,"median":-0.72206,"eighty":-0.217274,"marketCap":65690026},{"date":"2024-09-06","current":-0.318074,"twenty":-8.265055,"median":-0.717213,"eighty":-0.232229,"marketCap":62436303},{"date":"2024-09-13","current":-0.309114,"twenty":-8.265055,"median":-0.703942,"eighty":-0.261818,"marketCap":60677534},{"date":"2024-09-20","current":-0.309114,"twenty":-8.131099,"median":-0.695864,"eighty":-0.266732,"marketCap":60677534},{"date":"2024-09-27","current":-0.335993,"twenty":-8.122857,"median":-0.690704,"eighty":-0.267052,"marketCap":65953842},{"date":"2024-10-04","current":-0.302394,"twenty":-8.075619,"median":-0.687901,"eighty":-0.267052,"marketCap":59358457},{"date":"2024-10-11","current":-0.283355,"twenty":-8.009137,"median":-0.679968,"eighty":-0.267052,"marketCap":55621073},{"date":"2024-10-18","current":-0.291194,"twenty":-7.983748,"median":-0.6744,"eighty":-0.267159,"marketCap":57159996},{"date":"2024-10-25","current":-0.310624,"twenty":-7.968801,"median":-0.669321,"eighty":-0.272393,"marketCap":47926458},{"date":"2024-10-31","current":-0.225131,"twenty":-7.943557,"median":-0.665225,"eighty":-0.266988,"marketCap":34735690},{"date":"2024-11-08","current":-0.440288,"twenty":-7.915108,"median":-0.655868,"eighty":-0.264386,"marketCap":67932457},{"date":"2024-11-15","current":-0.438406,"twenty":-7.814583,"median":-0.660089,"eighty":-0.265354,"marketCap":49465381},{"date":"2024-11-22","current":-0.555839,"twenty":-7.759969,"median":-0.651671,"eighty":-0.266473,"marketCap":62715270},{"date":"2024-11-29","current":-0.397863,"twenty":-7.714328,"median":-0.643895,"eighty":-0.266924,"marketCap":44890930},{"date":"2024-12-06","current":-0.452472,"twenty":-7.61671,"median":-0.638808,"eighty":-0.267052,"marketCap":51052430},{"date":"2024-12-13","current":-1.475344,"twenty":-7.552638,"median":-0.643895,"eighty":-0.267116,"marketCap":51713749},{"date":"2024-12-20","current":-1.427235,"twenty":-7.537079,"median":-0.654916,"eighty":-0.270299,"marketCap":50027431},{"date":"2024-12-27","current":-1.372711,"twenty":-7.525707,"median":-0.660089,"eighty":-0.272746,"marketCap":48116271},{"date":"2025-01-03","current":-1.411198,"twenty":-7.496689,"median":-0.666378,"eighty":-0.274619,"marketCap":49465325},{"date":"2025-01-10","current":-1.391955,"twenty":-7.428871,"median":-0.669321,"eighty":-0.279995,"marketCap":48790798},{"date":"2025-01-17","current":-1.411198,"twenty":-7.414138,"median":-0.6744,"eighty":-0.281115,"marketCap":49465325},{"date":"2025-01-24","current":-1.475344,"twenty":-7.413326,"median":-0.679492,"eighty":-0.282907,"marketCap":51713749},{"date":"2025-01-31","current":-1.417613,"twenty":-7.413123,"median":-0.686862,"eighty":-0.286042,"marketCap":49690168},{"date":"2025-02-07","current":-1.558733,"twenty":-7.376667,"median":-0.690284,"eighty":-0.290298,"marketCap":54636700},{"date":"2025-02-14","current":-1.31498,"twenty":-7.367553,"median":-0.691708,"eighty":-0.293682,"marketCap":46092689},{"date":"2025-02-21","current":-1.154617,"twenty":-7.351478,"median":-0.69471,"eighty":-0.295126,"marketCap":40471630},{"date":"2025-02-28","current":-0.782574,"twenty":-7.3307,"median":-0.703586,"eighty":-0.296621,"marketCap":27430771},{"date":"2025-03-07","current":-0.83389,"twenty":-7.28583,"median":-0.708558,"eighty":-0.298863,"marketCap":29229510},{"date":"2025-03-14","current":-0.987839,"twenty":-7.2566,"median":-0.721483,"eighty":-0.300067,"marketCap":34625728},{"date":"2025-03-21","current":-1.109715,"twenty":-7.250202,"median":-0.722406,"eighty":-0.300162,"marketCap":38897733},{"date":"2025-03-28","current":-1.205933,"twenty":-7.220029,"median":-0.736254,"eighty":-0.301503,"marketCap":42270369},{"date":"2025-04-04","current":-0.981424,"twenty":-7.180626,"median":-0.74087,"eighty":-0.303738,"marketCap":34400885},{"date":"2025-04-11","current":-0.962181,"twenty":-7.151252,"median":-0.74703,"eighty":-0.305202,"marketCap":33726358},{"date":"2025-04-17","current":-1.051984,"twenty":-7.128011,"median":-0.756072,"eighty":-0.306098,"marketCap":36874151},{"date":"2025-04-25","current":-1.084057,"twenty":-7.09682,"median":-0.782574,"eighty":-0.307609,"marketCap":37998363},{"date":"2025-05-02","current":-1.00766,"twenty":-7.079277,"median":-0.830348,"eighty":-0.308873,"marketCap":35320491},{"date":"2025-05-09","current":-1.064813,"twenty":-7.065293,"median":-0.840304,"eighty":-0.309114,"marketCap":37323836},{"date":"2025-05-16","current":-0.772881,"twenty":-7.030333,"median":-0.830348,"eighty":-0.309562,"marketCap":44743635},{"date":"2025-05-23","current":-1.030083,"twenty":-7.007964,"median":-0.83389,"eighty":-0.310234,"marketCap":59633580},{"date":"2025-05-30","current":-0.943209,"twenty":-7.005054,"median":-0.859548,"eighty":-0.310234,"marketCap":54604242},{"date":"2025-06-06","current":-0.794281,"twenty":-6.999916,"median":-0.864146,"eighty":-0.310234,"marketCap":45982519},{"date":"2025-06-13","current":-0.728091,"twenty":-6.987052,"median":-0.852197,"eighty":-0.310234,"marketCap":42150643},{"date":"2025-06-20","current":-0.740502,"twenty":-6.96535,"median":-0.83389,"eighty":-0.310234,"marketCap":42869119},{"date":"2025-06-27","current":-0.790144,"twenty":-6.956919,"median":-0.830966,"eighty":-0.310234,"marketCap":45743027},{"date":"2025-07-03","current":-0.819102,"twenty":-6.956919,"median":-0.830348,"eighty":-0.310546,"marketCap":47419473},{"date":"2025-07-11","current":-0.893566,"twenty":-6.942935,"median":-0.830276,"eighty":-0.311208,"marketCap":51730334},{"date":"2025-07-18","current":-0.910114,"twenty":-6.906855,"median":-0.831513,"eighty":-0.31225,"marketCap":52688303},{"date":"2025-07-25","current":-1.307254,"twenty":-6.866559,"median":-0.840304,"eighty":-0.31337,"marketCap":75679563},{"date":"2025-08-01","current":-1.398783,"twenty":-6.825369,"median":-0.855873,"eighty":-0.313961,"marketCap":80978329},{"date":"2025-08-08","current":-1.385989,"twenty":-6.796651,"median":-0.868745,"eighty":-0.314582,"marketCap":80237673},{"date":"2025-08-11","current":-1.381724,"twenty":-6.791544,"median":-0.870814,"eighty":-0.314714,"marketCap":79990788}],"updateTime":1755036516148},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CELU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2559624104","title":"Celularity Inc. Faces Nasdaq Delisting Risk Over Delayed Financial Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2559624104","media":"Reuters","labels":["policyRegulatory","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559624104?lang=en_us&edition=fundamental","pubTime":"2025-08-13 05:01","pubTimestamp":1755032471,"startTime":"0","endTime":"0","summary":"Celularity Inc. has announced a delay in filing its quarterly report on Form 10-Q for the period ending March 31, 2025. The company received a notice from Nasdaq's Listings Qualification Staff on May 28, 2025, indicating non-compliance with Nasdaq's continued listing requirements due to this delay. Celularity submitted a compliance plan on August 1, 2025, and was granted until August 31, 2025, to file the required Form 10-Q for both the periods ending March 31, 2025, and June 30, 2025, to avoid potential delisting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celularity Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Sec","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nNDL2XYMbm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CELU"],"gpt_icon":0},{"id":"2555022377","title":"Celularity Inc. Announces $2 Million Private Placement with Institutional Investor for Working Capital and Corporate Purposes","url":"https://stock-news.laohu8.com/highlight/detail?id=2555022377","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555022377?lang=en_us&edition=fundamental","pubTime":"2025-07-31 04:31","pubTimestamp":1753907482,"startTime":"0","endTime":"0","summary":"Celularity Inc. Announces $2 Million Private Placement with Institutional Investor for Working Capital and Corporate Purposes. Celularity Inc. has announced a private placement agreement with an institutional investor, involving the issuance and sale of 1,230,769 shares of Class A common stock and warrants to purchase an equal number of shares. Priced at $1.625 per share and warrant, the transaction is expected to generate gross proceeds of $2 million for the company. The warrants come with an exercise price of $1.50 per share and are valid for two years from issuance. The net proceeds from this private placement will be allocated towards working capital and general corporate purposes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cel","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250730:nNDL86Cjwz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELU","BK4139"],"gpt_icon":0},{"id":"2553265151","title":"Celularity Inc. Announces $1.035 Million Private Placement of Common Stock with Warrant Adjustments","url":"https://stock-news.laohu8.com/highlight/detail?id=2553265151","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553265151?lang=en_us&edition=fundamental","pubTime":"2025-07-23 04:31","pubTimestamp":1753216275,"startTime":"0","endTime":"0","summary":"Celularity Inc. has announced a securities purchase agreement with certain investors for a private placement involving the issuance and sale of 739,286 shares of its Class A common stock at a purchase price of $1.40 per share. In conjunction with this agreement, the company has also revised the exercise price of certain warrants held by these investors to $2.50 per share and extended their expiration date to June 30, 2030. The transaction, expected to close during the week of July 21, 2025, is anticipated to generate gross proceeds of $1,035,000, which the company plans to use for working capital and general corporate purposes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celularity Inc. published the original content used to generat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250722:nNDL6MnGFx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CELU"],"gpt_icon":0},{"id":"2551312890","title":"Celularity Inc. Files Initial Beneficial Ownership Statement for Interim CFO Joseph DosSantos","url":"https://stock-news.laohu8.com/highlight/detail?id=2551312890","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551312890?lang=en_us&edition=fundamental","pubTime":"2025-07-16 20:24","pubTimestamp":1752668699,"startTime":"0","endTime":"0","summary":"Celularity Inc. has filed an initial statement of beneficial ownership, naming Joseph DosSantos as the beneficial owner. DosSantos holds the position of Interim CFO at the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celularity Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 16, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250716:nNDL7VN9bK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELU","BK4139"],"gpt_icon":0},{"id":"2550843625","title":"Celularity Inc. Files Initial Statement of Beneficial Ownership for Director Vincent LeVien","url":"https://stock-news.laohu8.com/highlight/detail?id=2550843625","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550843625?lang=en_us&edition=fundamental","pubTime":"2025-07-10 21:29","pubTimestamp":1752154154,"startTime":"0","endTime":"0","summary":"Celularity Inc. has filed an initial statement of beneficial ownership with the United States Securities and Exchange Commission. The filing lists Vincent LeVien as a beneficial owner in the role of Director. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celularity Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 10, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250710:nNDL224Pyp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELU","BK4139"],"gpt_icon":0},{"id":"2542340693","title":"BRIEF-Celularity Announces Chief Financial Officer Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2542340693","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542340693?lang=en_us&edition=fundamental","pubTime":"2025-06-11 04:42","pubTimestamp":1749588122,"startTime":"0","endTime":"0","summary":"BRIEF-Celularity Announces Chief Financial Officer TransitionCelularity Inc CELU.O:CELULARITY ANNOUNCES CHIEF FINANCIAL OFFICER TRANSITIONCELULARITY INC - TERMINATES CFO DAVID BEERS EFFECTIVE IMMEDIAT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nTUA9R6YSG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELUW","BK4139","CELU"],"gpt_icon":0},{"id":"2542470563","title":"Celularity Inc. Appoints Interim CFO Joseph DosSantos Following David Beers' Departure","url":"https://stock-news.laohu8.com/highlight/detail?id=2542470563","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542470563?lang=en_us&edition=fundamental","pubTime":"2025-06-11 04:31","pubTimestamp":1749587466,"startTime":"0","endTime":"0","summary":"Celularity Inc. announced the termination of its Chief Financial Officer, David Beers, effective immediately. Joseph DosSantos, the company's current Senior Vice President Finance, has been appointed as interim CFO while a search for a new CFO is conducted. During this transition, Celularity has retained the CFO Squad to provide outsourced accounting and consulting services.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celularity Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 10, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nNDL6ydRTK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELU","BK4139"],"gpt_icon":0},{"id":"2542471463","title":"Press Release: Celularity Announces Chief Financial Officer Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2542471463","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542471463?lang=en_us&edition=fundamental","pubTime":"2025-06-11 04:15","pubTimestamp":1749586500,"startTime":"0","endTime":"0","summary":"FLORHAM PARK, N.J., June 10, 2025  -- Celularity Inc.  , a regenerative and cellular medicine company, today announced that it terminated the employment of its Chief Financial Officer , David Beers, effective immediately. Mr. Beer's termination was not related to the Company's financial or operating results or to any disagreements or concerns regarding the Company's financial or reporting practices. Mr. Beers was terminated \"without cause\" under the terms of his employment agreement dated April 1, 2022, as amended and restated, and, subject to his compliance with its terms, Mr. Beers will be entitled to the payments and benefits provided therein following a termination without cause.Effective as of June 10, 2025, the Company appointed Joseph DosSantos, its current Senior Vice President Finance, as the Company's interim CFO while the Company conducts a search for a new CFO. Mr. DosSantos will continue to serve as the Company's Senior Vice President Finance during his time as interim CFO","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CELU"],"gpt_icon":0},{"id":"2541893308","title":"Celularity Inc. Appoints Vincent LeVien as New Class II Director and Committee Member","url":"https://stock-news.laohu8.com/highlight/detail?id=2541893308","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541893308?lang=en_us&edition=fundamental","pubTime":"2025-06-07 04:30","pubTimestamp":1749241858,"startTime":"0","endTime":"0","summary":"Celularity Inc. has announced the appointment of Vincent LeVien as a Class II director on its Board of Directors, effective June 5, 2025. Mr. LeVien will also serve as a member of the Audit Committee and the Nominating and Corporate Governance Committee. He is currently the Chairman and CEO of I Got a Guy, Inc., a network consulting firm.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celularity Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 06, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250606:nNDLRz3Np:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CELU"],"gpt_icon":0},{"id":"2537544419","title":"Celularity Inc. Files Amendment to 10-K Annual Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2537544419","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537544419?lang=en_us&edition=fundamental","pubTime":"2025-05-22 05:30","pubTimestamp":1747863057,"startTime":"0","endTime":"0","summary":"Celularity Inc. has filed an amendment to the 10-K annual report for the fiscal year ended December 31, 2024. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celularity Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 21, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDLJ9zPP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELU","BK4139"],"gpt_icon":0},{"id":"2537259966","title":"Celularity Inc. Extends Promissory Note Maturity, Issues 100,000 Shares with Piggyback Registration Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2537259966","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537259966?lang=en_us&edition=fundamental","pubTime":"2025-05-21 04:52","pubTimestamp":1747774375,"startTime":"0","endTime":"0","summary":"Celularity Inc. has announced a strategic agreement with YA II PN, Ltd. that includes the issuance of 100,000 shares of the company's restricted common stock. This move comes as part of an arrangement to extend the maturity date of a Convertible Promissory Note originally dated March 13, 2024, from May 12, 2025, to August 15, 2025. The newly issued shares will have piggyback registration rights, allowing for their resale to be included in any future registration statement filed by Celularity Inc.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celularity Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchang","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nNDL3H7WsM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELU","BK4139"],"gpt_icon":0},{"id":"2536340242","title":"Celularity Inc. Announces Resignation of Board Director Dean Kehler, Citing No Disagreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2536340242","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536340242?lang=en_us&edition=fundamental","pubTime":"2025-05-17 04:16","pubTimestamp":1747426572,"startTime":"0","endTime":"0","summary":"Celularity Inc. announced that Dean Kehler has resigned from the Board of Directors, effective May 14, 2025. The company clarified that his resignation was not due to any disagreement with the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celularity Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 16, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nNDL35rx40:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELU","BK4139"],"gpt_icon":0},{"id":"2535064771","title":"Celularity Inc. Advances Placental-Derived Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2535064771","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535064771?lang=en_us&edition=fundamental","pubTime":"2025-05-14 12:41","pubTimestamp":1747197696,"startTime":"0","endTime":"0","summary":"Celularity Inc. ( ($CELU) ) has released its Q4 earnings. Here is a breakdown of the information Celularity Inc. presented to its investors. Celula...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/celularity-inc-advances-placental-derived-therapies?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/celularity-inc-advances-placental-derived-therapies?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CELU"],"gpt_icon":0},{"id":"2534948252","title":"Press Release: Celularity Announces Full Year 2024 Operating and Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2534948252","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534948252?lang=en_us&edition=fundamental","pubTime":"2025-05-09 21:15","pubTimestamp":1746796500,"startTime":"0","endTime":"0","summary":"Net revenues for the year ending December 31, 2024, totaled $54.2 million, an increase of $31.4 million, or 138.1%, compared to the previous year.FLORHAM PARK, N.J., May 09, 2025  -- Celularity Inc.  , a regenerative and cellular medicine company, today announced operating and financial results for the year ended December 31, 2024.Net revenues for the year ended December 31, 2024, was $54.2 million, an increase of $31.4 million, or 138.1%, compared to the prior year period. This growth was primarily due to a $22.2 million increase in product sales in wound care applications, which increased 168.7% over the prior year.Total operating expenses for the year ended December 31, 2024, were $92.6 million, a decrease of $122.5 million, or 57.0%, compared to 2023. The decrease in operating expenses is attributable to the absence of goodwill and in-process research and development, or IPR&D, impairments in 2024. Loss from operations for the year ending December 31, 2024, was $38.4 million, a dec","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELU"],"gpt_icon":0},{"id":"2534146611","title":"Celularity Inc. Reports Significant Variation in Net Revenues and Maintains Investment Focus Despite Short-Term Profitability Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2534146611","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534146611?lang=en_us&edition=fundamental","pubTime":"2025-05-09 06:09","pubTimestamp":1746742171,"startTime":"0","endTime":"0","summary":"Celularity Inc. Reports Significant Variation in Net Revenues and Maintains Investment Focus Despite Short-Term Profitability Challenges. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celularity Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 08, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nNDL9XmMzB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELU"],"gpt_icon":0},{"id":"2530541196","title":"Celularity receives notice regarding non-payment of Nasdaq fees","url":"https://stock-news.laohu8.com/highlight/detail?id=2530541196","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530541196?lang=en_us&edition=fundamental","pubTime":"2025-04-26 05:40","pubTimestamp":1745617222,"startTime":"0","endTime":"0","summary":"Celularity (CELU) announced that Nasdaq has notified the company that it has not paid certain fees required by Listing Rule 5250(f) and accordingly...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/celularity-receives-notice-regarding-non-payment-of-nasdaq-fees?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/celularity-receives-notice-regarding-non-payment-of-nasdaq-fees?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":[".IXIC","USAW.SI","MNQmain","TSYW.SI","LU2210149790.SGD","BK4585","BK4588","TQQQ","CELU","NVIW.SI","LU2210150020.SGD","BK4139","IE00BKPKM429.USD","QID","LU2095319765.USD","NDAQ","IE00B64PRP62.GBP","BK4112","NQmain","SQQQ","IE00BGHQF748.EUR","PSQ","USJW.SI","QLD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2527157691","title":"Celularity welcomes CMS action on Medicare LCD for skin substitutes products","url":"https://stock-news.laohu8.com/highlight/detail?id=2527157691","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527157691?lang=en_us&edition=fundamental","pubTime":"2025-04-14 20:19","pubTimestamp":1744633178,"startTime":"0","endTime":"0","summary":"Celularity (CELU) welcomes action by the Centers for Medicare & Medicaid Services, or CMS, to revise to January 1, 2026, the effective date of the ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/celularity-welcomes-cms-action-on-medicare-lcd-for-skin-substitutes-products?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/celularity-welcomes-cms-action-on-medicare-lcd-for-skin-substitutes-products?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU1894683264.USD","LU2637428348.USD","LU1894683348.USD","LU2500361329.USD","BK4208","LU2346227817.USD","BK4139","BK4588","CMS","CELU"],"gpt_icon":0},{"id":"2527115461","title":"Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2527115461","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527115461?lang=en_us&edition=fundamental","pubTime":"2025-04-14 20:00","pubTimestamp":1744632000,"startTime":"0","endTime":"0","summary":"Action delays to January 1, 2026, the effective date of a Biden-era Medicare LCD for skin substitute products used to treat diabetic foot ulcers and venous leg ulcers. FLORHAM PARK, N.J., April 14, 2025  -- Celularity Inc.  , a regenerative and cellular medicine company, welcomes action by the Centers for Medicare & Medicaid Services, or CMS, to revise to January 1, 2026, the effective date of the Medicare Local Coverage Determination, or LCD, titled “Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers” first published in November 2024.An LCD is a determination by a Medicare Administrative Contractor, or MAC, whether to cover a particular service on aMAC-wide, basis.A MAC processes Medicare Part A and Part B claims for a defined geographic area, or jurisdiction, and develops LCDs within its particular jurisdiction.Celularity Inc.  is a regenerative and cellular medicine company developing and commercia","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/celularity-welcomes-cms-action-medicare-120000703.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CMS","LU1894683264.USD","CELUW","LU2500361329.USD","LU2346227817.USD","LU1894683348.USD","CELU","BK4139","BK4208","LU2637428348.USD","BK4588","BK4585"],"gpt_icon":0},{"id":"2525010862","title":"Celularity Announces Publication of “Senescence, NK cells, and cancer: navigating the crossroads of aging and disease” in the April 4, 2025, Issue of Frontiers in Immunology","url":"https://stock-news.laohu8.com/highlight/detail?id=2525010862","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525010862?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:00","pubTimestamp":1744027200,"startTime":"0","endTime":"0","summary":"Highlights the unique therapeutic potential of Celularity clinical-stagecandidate CYNK-001 in age-related diseases. In “Senescence, NK cells, and cancer: navigating the crossroads of aging and disease,” Celularity scientists discuss how aging may influence the battle between the immune system and cancer, and the implications of senoablative Natural Killer, or NK, cells in disease progression. They emphasize that “preserving the function of NK cells during aging is essential for promoting healthy aging and longevity.” They conclude the publication by discussing the potential of adoptive NK cell therapy as a countermeasure to age-related decline in immunological function, a condition called immunosenescence.This press release includes “forward-looking statements” . All statements other than statements of historical facts are “forward-looking statements,” including those relating to future events. In some cases","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/celularity-announces-publication-senescence-nk-120000951.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CELUW","BK4139","CELU"],"gpt_icon":0},{"id":"2524690522","title":"BRIEF-Celularity Files For Non-Timley 10-K - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2524690522","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524690522?lang=en_us&edition=fundamental","pubTime":"2025-04-01 06:24","pubTimestamp":1743459884,"startTime":"0","endTime":"0","summary":"BRIEF-Celularity Files For Non-Timley 10-K - SEC FilingMarch 31  - Celularity Inc CELU.O:CELULARITY FILES FOR NON-TIMLEY 10-K - SEC FILINGCELULARITY: SEES NET REVENUES FOR YEAR ENDED DEC 31, 2024 OF $54.2 MILLIONSource text: [ID:n0001641172-25-001823]Further company coverage: CELU.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE1GZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELU","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":24,"code":"91000000","status":"200"}]}}